MedTrace Logo

Study of the Soliton Rapid Acoustic Pulse (RAP) Device for the Treatment of Cellulite

NCT04065711 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 67

Last updated 2021-09-22

No results posted yet for this study

Summary

To evaluate the safety, and efficacy of Soliton's Rapid Acoustic Pulse (RAP) device for the temporary improvement in the appearance of cellulite.

Conditions

  • Cellulite

Interventions

DEVICE

Soliton's Rapid Acoustic Pulse (RAP)

Treatment for the temporary improvement in the appearance of cellulite.

Sponsors & Collaborators

  • Soliton

    lead INDUSTRY

Principal Investigators

  • Christopher Capelli, MD · Soliton, Inc.

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-07-20
Primary Completion
2021-07-20
Completion
2021-08-26
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04065711 on ClinicalTrials.gov